Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Buy
62
BLTE Quote, Financials, Valuation and Earnings
Last price:
$154.54
Seasonality move
:
-3.53%
Day range:
$153.62 - $155.48
52-week range:
$49.00 - $162.00
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
21.21x
Volume:
72K
Avg. volume:
256.8K
1-year change:
146.12%
Market cap:
$5.8B
Revenue:
--
EPS (TTM):
-$1.92
Earnings Data
Next earnings date for BLTE
Mar 10
2026
Most recent earnings per share
-$0.65
Missed by $0.16
(Nov 10/2025)
Consensus Estimate
-$0.49
(Nov 10/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
BLTE Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/10/2026 | Q4 | -- | -- | -- | -$0.51 | -- |
| 11/10/2025 | Q3 | -- | -- | -$0.65 | -$0.49 | -$0.16 |
| 08/11/2025 | Q2 | -- | -- | -$0.50 | -$0.42 | -$0.08 |
| 05/12/2025 | Q1 | -- | -- | -$0.45 | -$0.37 | -$0.08 |
| 03/17/2025 | Q4 | -- | -- | -$0.32 | -$0.31 | -$0.01 |
| 11/12/2024 | Q3 | -- | -- | -$0.28 | -$0.30 | $0.02 |
| 08/12/2024 | Q2 | -- | -- | -$0.31 | -$0.26 | -$0.05 |
| 05/14/2024 | Q1 | -- | -- | -$0.27 | -$0.29 | $0.02 |
| 03/12/2024 | Q4 | -- | -- | -$0.25 | -$0.30 | $0.05 |
| 11/14/2023 | Q3 | -- | -- | -$0.40 | -- | -- |
| 08/09/2023 | Q2 | -- | -- | -$0.26 | -- | -- |
| 05/10/2023 | Q1 | -- | -- | -$0.33 | -- | -- |
| 03/31/2023 | Q4 | -- | -- | -$0.31 | -- | -- |
| 12/15/2022 | Q3 | -- | -- | -$0.10 | -- | -- |
| 08/10/2022 | Q2 | -- | -- | -$0.12 | -- | -- |
| 03/31/2022 | Q1 | -- | -- | -$0.04 | -- | -- |
Belite Bio, Inc. Earnings Questions
-
How Much did Belite Bio, Inc. Generate in Revenue Last Quarter?
Belite Bio, Inc. reported -- worth of top line sales in its most recent quarter.
-
Did Belite Bio, Inc. Beat Earnings Last Quarter?
Belite Bio, Inc. announced earnings per share of -$0.65 which represents a miss of analyst forecast a -$0.49 per share.
-
Is Belite Bio, Inc. Profitable?
Belite Bio, Inc. reported -$347K that represents -$0.01 per share over the last quarter.
-
What is the Analyst Consensus for Belite Bio, Inc. EPS Next Year?
Belite Bio, Inc.'s earnings are forecast to decrease from -$1.18 per share to -$1.18 per share next year representing a decrease of -80.8%.
-
When is Belite Bio, Inc.'s Earnings Date?
Belite Bio, Inc.'s next earnings date is March 10, 2026.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 65x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
72
GLTO alert for Dec 27
Galecto, Inc. [GLTO] is up 16.92% over the past day.
Sell
20
SMX alert for Dec 27
SMX (Security Matters) Plc [SMX] is down 15.76% over the past day.
Sell
11
CDNAF alert for Dec 27
Canadian Tire Corp. Ltd. [CDNAF] is down 10% over the past day.
